The best allergen immunotherapy choice for mite allergic patients

Expert Review of Clinical Immunology

Volumn 12, Issue 6, 2016, Pages 603-604

  Ciprandi, Giorgio ^a   Incorvaia, Cristoforo ^b   Masieri, Simonetta ^c   Buttafava, Serena ^d   Frati, Franco ^d  

^a UNIVERSITY OF GENOA   (Italy)

^b ICP Hospital   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d Medical and Scientific Department   (Italy)

Author keywords

Allergen immunotherapy; house dust mites; immunotherapy schedule; prescription; seasonal fluctuation

Indexed keywords

HOUSE DUST ALLERGEN; RECOMBINANT ALLERGEN; ALLERGEN; IMMUNOGLOBULIN E;

ADOLESCENCE; ADULTHOOD; AGING; ALLERGIC RHINITIS; ASTHMA; AUTUMN; EDITORIAL; EOSINOPHIL COUNT; FALLING; HOUSE DUST ALLERGY; HUMAN; IMMUNOLOGIST; IMMUNOTHERAPY; NONHUMAN; PRESCRIPTION; SEASONAL VARIATION; SPRING; SUMMER; VIRUS INFECTION; WINTER; ANIMAL; DESENSITIZATION; ENVIRONMENTAL EXPOSURE; EVIDENCE BASED MEDICINE; HYPERSENSITIVITY; IMMUNOLOGY; METABOLISM; MITE; PREVENTION AND CONTROL; PROCEDURES;

ALLERGENS; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; DESENSITIZATION, IMMUNOLOGIC; ENVIRONMENTAL EXPOSURE; EVIDENCE-BASED MEDICINE; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; MITES;

EID: 84961391242     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/1744666X.2016.1162712     Document Type: Editorial

References (13)

1. K.Blomme, P.Tomassen, H.Lapeere, et al. Prevalence of allergic sensitization versus allergic rhinitis symptoms in an unselected population. Int Arch Allergy Immunol. 2013;160:200–207.
2. M.DeAmici, G.Ciprandi The age impact on serum total and allergen-specific IgE. Allergy Asthma Immunol Res. 2013;5:170–174.
3. J.C.Bessot, G.Pauli. Mite allergens: an overview. Eur Ann Allergy Clin Immunol. 2011;43:141–156.
4. G.Ciprandi, G.Marseglia, C.Klersy, et al. Relationships between allergic inflammation and nasal airflow in children with persistent allergic rhinitis due to mite sensitization. Allergy. 2005;60:957–960.
5. H.Coban, Y.Aydemir. The relationship between allergy and asthma control, quality of life, and emotional status in patients with asthma: a cross-sectional study. Allergy Asthma Clin Immunol. 2014;10:67.
6. F.Frati, S.Scurati, I.Dell’Albani, et al. Evaluation of house dust mite allergy in real life: patients’ characteristics and satisfaction with treatment. Eur Ann Allergy Clin Immunol. 2014;46:17–21.
7. N.W.Johnston, S.L.Johnston, G.R.Norman, et al. The September epidemic of asthma hospitalization: school children as disease vectors. J Allergy Clin Immunol. 2006;117:557–562.
8. F.Occasi, G.De Castro, A.Zicari, et al. Sublingual immunotherapy in children and its potential beneficial collateral effect on respiratory tract infections. Curr Med Res Opin. 2015;31:939–941.
9. T.A.Platts-Mills, M.L.Hayden, M.D.Chapman, et al. Seasonal variation in dust mite and grass-pollen allergens in dust from the houses of patients with asthma. J Allergy Clin Immunol. 1987;79:781–791.
10. M.Gelardi, D.G.Peroni, C.Incorvaia, et al. Seasonal changes in nasal cytology in mite-allergic patients. J Inflamm Res. 2014;7:39–44.
11. G.Cadario, G.Ciprandi, G.Di Cara, et al. Comparison between continuous or intermittent schedules of sublingual immunotherapy for house dust mites: effects on compliance, patients satisfaction, quality of life and safety. Int J Immunopathol Pharmacol. 2008;21:471–473.
12. M.Jutel, I.Agache, S.Bonini, et al. International consensus on allergy immunotherapy. J Allergy Clin Immunol. 2015;136:556–568.
13. L.Wang, J.Yin, R.Fadel, et al. House dust mite sublingual immunotherapy is safe and appears to be effective in moderate, persistent asthma. Allergy. 2014;69:1181–1188.